Biometrics that count. In Ghana, frontline health workers are using Simprints’ biometric technology to make sure vaccines reach the child they are meant for. By linking each patient to a unique digital identity, no dose is wasted, no record is lost, and no child is overlooked. For health systems facing challenges of duplication, misidentification, and […]
LunaVax Insights: Biometrics for Vaccine Equity in Ghana Read More »
A first for Africa: Nigeria sustains WHO’s ML3 status. In August 2025, Nigeria became the first country in Africa to successfully sustain the World Health Organization’s Maturity Level 3 (ML3) for regulating medicines and vaccines. This milestone confirms that the country’s system is strong enough to support safe, local vaccine production, a step toward self-reliance
LunaVax Insights: Nigeria sustains WHO milestone for vaccine production Read More »
Needle-free. No clinic required. In Nigeria and other regions where distance and infrastructure limit access, Microneedle vaccine patches (MAPs) could bring vaccines closer to the people who need them most. MAPs are an emerging vaccine delivery method designed to be painless, easy to apply, and stable without cold-chain requirements for extended periods. Instead of requiring
LunaVax Insights: Microneedle Patches and the Future of Vaccine Access Read More »
20,000 vaccine deliveries. No roads required. In Bayelsa, Nigeria, malaria vaccines are now reaching hard-to-reach communities by air. A Gavi-backed initiative, in partnership with Zipline, is delivering hope—one drone drop at a time—where traditional health delivery can’t go. At LunaVax, we spotlight bold solutions advancing last-mile vaccine access. From drones today to microneedle patches tomorrow,
LunaVax Insights: Drone-Powered Vaccine Access in Nigeria Read More »
In 2017, a groundbreaking study challenged the global vaccine system.The Vaccine Manufacturing and Procurement in Africa (VMPA) study (PDF) confirmed what many already knew on the ground: Even when African countries invest in local vaccine manufacturing, they’re still being locked out of the very systems meant to deliver vaccines to their own people. Procurement barriers.
Join the Movement: What If Advocacy Didn’t Look the Way You Expected? Read More »
To deliver vaccines equitably, we need more than just doses , we need a system.The LunaChain offers a new model: a connected, community-powered network built to get vaccines where they’re needed most. The Access Problem Isn’t Just Supply. It’s Systems. Vaccines don’t save lives on their own. Delivery does. Across Africa, millions of children remain
Partner with LunaVax to advance vaccine access Read More »
At LunaVax, we’re reimagining vaccine delivery across Lagos, Abuja, Adamawa and Anambra, Nigeria, with something as small as a patch. Microneedle vaccine patches (MAPs) are an emerging innovation that could help make vaccines safer, simpler, and easier to deliver — especially in communities with limited access to cold chains, trained health workers, or reliable power
Volunteer to Help Us Pilot the Future of Vaccines — One Patch at a Time Read More »
LunaVax’s MAP Vaccine Pilot in Nigeria At LunaVax, we believe that innovation in global health doesn’t end in the lab—it begins when breakthrough tools reach the communities that need them most. You can’t drive vaccine access without reaching the last mile. This year, we’re launching a feasibility pilot of microneedle vaccine patches (MAPs) for measles
Help us reimagine vaccine access: Join Nigeria’s MAP Vaccine Pilot Study Read More »
Introducing Our Digital Ambassador: A New Voice for the Lunaverse At LunaVax, we’ve always believed that science needs storytellers — voices that can translate complexity into clarity, and mission into meaning. That’s why we’re excited to introduce Luna D. Vax, our new digital ambassador. Luna D. was created by the LunaVax team to serve as
Luna D. Vax Joins the Team: Sharing Our Mission, One Story at a Time Read More »
A New Chapter for LunaVax: Expanding Vaccine Access Through Innovation At LunaVax, we believe no child should be left behind because of where they live.Across the world, millions of children and communities still lack access to life-saving vaccines, a gap we are determined to help close. We’re excited to announce a major step forward in
Lunavax launches MAP vaccine pilot with harvard medical school Read More »
